|
|
||||||||
Ann Thorac Surg 2005;79:S2238-S2247
© 2005 The Society of Thoracic Surgeons
Division of Cardiovascular Surgery, Toronto General Hospital, University Health Network, Department of Surgery, University of Toronto, Heart and Stroke Foundation/Richard Lewar Centre of Excellence, Toronto, Ontario, Canada
Accepted for publication February 21, 2005.
* Address reprint requests to Dr Yau, Division of Cardiovascular Surgery, Toronto General Hospital, University Health Network, 13EN-239, 200 Elizabeth St, Toronto, Ontario, Canada, M5G 2C4 (E-mail: terry.yau{at}utoronto.ca).
Presented at the 4th Annual Lillehei Heart Institute Symposium Celebrating the 50th Anniversary of Open-Heart Surgery by Cross Circulation, Minneapolis, MN, Oct 1920, 2004.
Cellular therapy for acute myocardial infarction and ischemic cardiomyopathy has entered clinical trials across the globe. Early promising results have now provided the justification for larger randomized and blinded trials to address the efficacy of cellular therapy. A variety of fresh or cultured autologous cells have been delivered by catheter-guided endocardial, catheter-guided intracoronary, catheter-guided transvenous, and direct epicardial routes. This review will summarize the clinical data and highlight salient basic science data that support the ongoing efforts to identify the optimal cellular therapy both for acute myocardial infarction and chronic ischemic cardiomyopathy patients.
This article has been cited by other articles:
![]() |
S. S. Fazel, L. Chen, D. Angoulvant, S.-H. Li, R. D. Weisel, A. Keating, and R.-K. Li Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury FASEB J, March 1, 2008; 22(3): 930 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Suuronen, J. Price, J. P. Veinot, K. Ascah, V. Kapila, X.-W. Guo, S. Wong, T. G. Mesana, and M. Ruel Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1249 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Prockop and S. D. Olson Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions Blood, April 15, 2007; 109(8): 3147 - 3151. [Full Text] [PDF] |
||||
![]() |
S. Fazel Bone marrow cell therapy for heart disease: A few good men and women wanted J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 599 - 600. [Full Text] [PDF] |
||||
![]() |
R. H. Lee, M. J. Seo, R. L. Reger, J. L. Spees, A. A. Pulin, S. D. Olson, and D. J. Prockop Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice PNAS, November 14, 2006; 103(46): 17438 - 17443. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |